LEUKOSTRAT
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 23 Oct 2024)
What this means for you
Registered since 11 Dec 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86560545
- Registration number
- 5628108
- Mark type
- Stylized text
- Filed
- 11 Mar 2015
- Published for opposition
- 11 Aug 2015
- Registered
- 11 Dec 2018
- Attorney of record
- Sarah W. Matthews
Goods and services
- Class 001 — Chemicals: Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use
- Class 005 — Pharmaceuticals: Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
- Class 042 — Scientific and technological services: DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
- Class 044 — Medical, beauty and agricultural services: DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
Owner
- INVIVOSCRIBE, INC., SAN DIEGO, CA, US
- INVIVOSCRIBE, INC., SAN DIEGO, CA, US
- Invivoscribe Technologies, Inc., San Diego, CA, US
- Invivoscribe Technologies, Inc., San Diego, CA, US
Prosecution history
- 23 Oct 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 23 Oct 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Oct 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Apr 2024 — TEAS SECTION 8 & 15 RECEIVED
- 11 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
- 03 Nov 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Nov 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Nov 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Oct 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Oct 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Sept 2018 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Sept 2018 — NON-FINAL ACTION E-MAILED
- 24 Sept 2018 — SU - NON-FINAL ACTION - WRITTEN
- 13 Sept 2018 — STATEMENT OF USE PROCESSING COMPLETE